"Adoptive Transfer" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (IMMUNOTHERAPY, ADOPTIVE).
Descriptor ID |
D019264
|
MeSH Number(s) |
E02.095.465.425.400.330.050 E05.478.550.520.050
|
Concept/Terms |
Adoptive Cell Transfer- Adoptive Cell Transfer
- Adoptive Cell Transfers
- Cell Transfer, Adoptive
- Cell Transfers, Adoptive
|
Below are MeSH descriptors whose meaning is more general than "Adoptive Transfer".
Below are MeSH descriptors whose meaning is more specific than "Adoptive Transfer".
This graph shows the total number of publications written about "Adoptive Transfer" by people in this website by year, and whether "Adoptive Transfer" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2004 | 0 | 2 | 2 |
2005 | 0 | 2 | 2 |
2006 | 0 | 3 | 3 |
2007 | 1 | 2 | 3 |
2008 | 2 | 1 | 3 |
2009 | 1 | 2 | 3 |
2010 | 0 | 6 | 6 |
2011 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2013 | 0 | 4 | 4 |
2014 | 0 | 1 | 1 |
2015 | 2 | 3 | 5 |
2016 | 0 | 4 | 4 |
2017 | 2 | 4 | 6 |
2018 | 1 | 4 | 5 |
2019 | 1 | 2 | 3 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adoptive Transfer" by people in Profiles.
-
Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation. Front Immunol. 2021; 12:631365.
-
ER stress-induced mediator C/EBP homologous protein thwarts effector T?cell activity in tumors through T-bet repression. Nat Commun. 2019 03 20; 10(1):1280.
-
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019 02 25; 129(4):1551-1565.
-
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity. Nat Commun. 2019 02 22; 10(1):912.
-
Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells. Front Immunol. 2018; 9:1782.
-
Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione. Immunobiology. 2018 10; 223(10):549-554.
-
In Vitro Priming of Adoptively Transferred T Cells with a ROR? Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018 07 15; 78(14):3888-3898.
-
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells. Cancer Res. 2018 06 01; 78(11):3067-3074.
-
When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell Mol Immunol. 2018 May; 15(5):458-469.
-
Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice. Sci Signal. 2017 Dec 19; 10(510).